Skip to main content
. 2023 Jun 26;14:1144918. doi: 10.3389/fphar.2023.1144918

TABLE 2.

Targetable receptors in adipose tissue and their actions and limitations.

Receptor Beneficial action Actions on thermogenic adipose tissue Potential mechanism Reasons for their limitation
β2/β3-Adrenergic receptors Agonism Increase BAT activation; induce beiging Activate cAMP/PKA signaling; co-express with UCP1 Side effects such as cardiovascular dysfunction
A2A/A2B adenosine receptors Agonism Increase BAT activation and induce beiging Heterodimerization of A2B and A2A receptors Uncertain
PPARα/β/γ/δ Agonism Regulates BAT biology; induces beiging; counters against HFD-induced BAT whitening Cooperates with PGC-1α and PRDM16; activates the thermogenic pathway and enhances lipolysis; activates fatty acid oxidation Weight gain effect; side effects such as hepatotoxicity, myocardial infarction, bladder cancer, and heart failure
Glucocorticoid/mineralocorticoid receptors Antagonism Prevent HFD-induced lipid accumulation in BAT, decrease fat mass and body weight; induce beiging; enhance BAT function UCP1 “unmasking” Antagonism on androgen and progesterone receptors; risk of hyperkalemia
Thyroid hormone receptors Agonism Induce beiging and promote adaptive thermogenesis; induce BAT proliferation Crosstalk between thyroid hormone receptor signaling and β-adrenergic receptor signaling; promote progenitor cell proliferation Uncertain